Elkiran, E. Et Al. 2005. Differential alteration of drug metabolizing enzyme activities in vivo after cyclophosphamide/doxorubicin administration in operable breast cancer patients.. 41st Annual Meeting of the American-Society-of-Clinical-Oncology , (Florida, United States Of America).

Elkiran, E., Altundag, K., Babaoglu, M., Yasar, U., Ozisik, Y., Guler, N., ... Dincel, A.(2005). Differential alteration of drug metabolizing enzyme activities in vivo after cyclophosphamide/doxorubicin administration in operable breast cancer patients. . 41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, United States Of America

Elkiran, ET Et Al. "Differential alteration of drug metabolizing enzyme activities in vivo after cyclophosphamide/doxorubicin administration in operable breast cancer patients.," 41st Annual Meeting of the American-Society-of-Clinical-Oncology, Florida, United States Of America, 2005

Elkiran, ET Et Al. "Differential alteration of drug metabolizing enzyme activities in vivo after cyclophosphamide/doxorubicin administration in operable breast cancer patients.." 41st Annual Meeting of the American-Society-of-Clinical-Oncology , Florida, United States Of America, 2005

Elkiran, E. Et Al. (2005) . "Differential alteration of drug metabolizing enzyme activities in vivo after cyclophosphamide/doxorubicin administration in operable breast cancer patients.." 41st Annual Meeting of the American-Society-of-Clinical-Oncology , Florida, United States Of America.

@conferencepaper{conferencepaper, author={ET Elkiran Et Al. }, title={Differential alteration of drug metabolizing enzyme activities in vivo after cyclophosphamide/doxorubicin administration in operable breast cancer patients.}, congress name={41st Annual Meeting of the American-Society-of-Clinical-Oncology}, city={Florida}, country={United States Of America}, year={2005}}